[89Zr]-Labeled antibody targeting glypican-1 developed as theranostic for pancreatic cancer June 27, 2022
Dual CXCR4/ACKR3 inhibitor in combination with ICT impedes 4T1 tumor growth and metastasis June 27, 2022
Silo in commercial evaluation license agreement for next-generation liposomes for autoimmune disease June 27, 2022
Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer June 27, 2022
RSS